In the latest trading session, 0.6 million Clearside Biomedical Inc (NASDAQ:CLSD) shares changed hands as the company’s beta touched 2.30. With the company’s most recent
Clearside Biomedical Inc (NASDAQ:CLSD) has a beta value of 2.31 and has seen 1.64 million shares traded in the last trading session. The company, currently
During the last session, Clearside Biomedical Inc (NASDAQ:CLSD)’s traded shares were 18.35 million, with the beta value of the company hitting 2.29. At the end
In today’s recent session, 14.21 million shares of the Clearside Biomedical Inc (NASDAQ:CLSD) have been traded, and its beta is 2.29. Most recently the company’s
The biotechnology industry develops mechanisms for treating health problems and tools for diagnosing them. It usually takes a great deal of research and funding for
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
